{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:20:18Z","timestamp":1790616018181,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.brachy.2019.08.005","type":"journal-article","created":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T07:42:17Z","timestamp":1568014937000},"page":"814-822","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["High-dose-rate vs. low-dose-rate interstitial brachytherapy boost for anal canal cancers"],"prefix":"10.1016","volume":"18","author":[{"given":"Leonel","family":"Varela Cagetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Zemmour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naji","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Minsat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjorie","family":"Ferr\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hughes","family":"Mailleux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Giovaninni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Lelong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile","family":"De Chaisemartin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Ries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora","family":"Poizat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Tallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Moureau-Zabotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2019.08.005_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"Cancer J Clin"},{"issue":"9","key":"10.1016\/j.brachy.2019.08.005_bib2","first-page":"4111","article-title":"Anal carcinoma: Surgery does not influence prognosis when performed prior to concurrent radiochemotherapy","volume":"33","author":"Budach","year":"2013","journal-title":"Anticancer Res"},{"key":"10.1016\/j.brachy.2019.08.005_bib3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ijrobp.2004.09.060","article-title":"Anal canal carcinoma: Early-stage tumors< or\u00a0=10 mm (T1 or Tis): Therapeutic options and original pattern of local failure after radiotherapy","volume":"62","author":"Ortholan","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.08.005_bib4","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","article-title":"Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal. A randomized controlled trial","volume":"299","author":"Ajani","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.brachy.2019.08.005_bib5","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(96)03409-5","article-title":"Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2019.08.005_bib6","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","volume":"15","author":"Bartelink","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2019.08.005_bib7","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1200\/JCO.1996.14.9.2527","article-title":"Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized intergroup study","volume":"14","author":"Flam","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2019.08.005_bib8","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","article-title":"Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): A randomised, phase 3, open-label, 2\u00d72 factorial trial","volume":"14","author":"James","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.brachy.2019.08.005_bib9","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1200\/JCO.2012.43.8085","article-title":"Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: Survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil\/mitomycin versus fluorouracil\/cisplatin","volume":"30","author":"Gunderson","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2019.08.005_bib10","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/sj.bjc.6605605","article-title":"Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomized UKCCCR Anal Cancer Trial (ACT I)","volume":"102","author":"Northover","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.brachy.2019.08.005_bib11","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0360-3016(01)01510-3","article-title":"The impact of gap duration on local control in anal canal carcinoma treated by split-course radiotherapy and concomitant chemotherapy","volume":"50","author":"Weber","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.08.005_bib12","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.ejso.2014.07.030","article-title":"Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"40","author":"Glynne-Jones","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.brachy.2019.08.005_bib13","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/0360-3016(89)90521-X","article-title":"Interstitial curietherapy in the conservative treatment of anal and rectal cancers","volume":"17","author":"Papillon","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.08.005_bib14","first-page":"505","volume":"23","author":"Gerbaulet","year":"2002"},{"key":"10.1016\/j.brachy.2019.08.005_bib15","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.brachy.2016.07.007","article-title":"Low-dose-rate interstitial brachytherapy boost for the treatment of anal canal cancers","volume":"16","author":"Cordoba","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2019.08.005_bib16","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.canrad.2014.08.001","article-title":"End of the commercialisation of 192Ir wires in France: Proposals of the groupe de Curieth\u00e9rapie de la SFRO","volume":"18","author":"Peiffert","year":"2014","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.brachy.2019.08.005_bib17","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ijrobp.2008.08.070","article-title":"Elective clinical target volumes for conformal therapy in anorectal cancer: A radiation therapy oncology group consensus panel contouring atlas","volume":"74","author":"Myerson","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.08.005_bib18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/02841867809127689","article-title":"The Paris system in interstitial radiation therapy","volume":"17","author":"Pierquin","year":"1978","journal-title":"Acta Radiol Oncol Radiat Phys Biol"},{"key":"10.1016\/j.brachy.2019.08.005_bib19","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/09553008514550461","article-title":"An 'incomplete-repair' model for survival after fractionated and continuous irradiations","volume":"47","author":"Thames","year":"1985","journal-title":"Int J Radiat Biol Relat Stud Phys Chem Med"},{"key":"10.1016\/j.brachy.2019.08.005_bib20","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0360-3016(95)00162-R","article-title":"Biologically effective dose distribution based on the linear quadratic model and its clinical relevance","volume":"33","author":"Lee","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.08.005_bib21","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0360-3016(99)00330-2","article-title":"A simple method of obtaining equivalent doses for use in HDR brachytherapy","volume":"46","author":"Nag","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.08.005_bib22","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0360-3016(96)00493-2","article-title":"Conservative treatment by irradiation of epidermoid cancers of the anal canal: Prognostic factors of tumoral control and complications","volume":"37","author":"Peiffert","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.08.005_bib23","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0360-3016(95)02182-5","article-title":"Quantitative comparisons of continuous and pulsed low dose rate regimens in a model late-effect system","volume":"34","author":"Brenner","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.08.005_bib24","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.radonc.2006.03.013","article-title":"Treatment of squamous cell anal canal carcinoma (SCACC) with pulsed dose rate brachytherapy: A retrospective study","volume":"79","author":"Bruna","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2019.08.005_bib25","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s00066-014-0628-y","article-title":"Role of brachytherapy in the treatment of cancers of the anal canal. Long-term follow-up and multivariate analysis of a large monocentric retrospective series","volume":"190","author":"Lestrade","year":"2014","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.brachy.2019.08.005_bib26","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.brachy.2015.03.006","article-title":"Interstitial pulsed-dose-rate brachytherapy for the treatment of squamous cell anal carcinoma: A retrospective single institution analysis","volume":"14","author":"Boukhelif","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2019.08.005_bib27","first-page":"388","article-title":"Dosimetric and clinical outcome in image-based high-dose-rate interstitial brachytherapy for anal cancer","volume":"4","author":"Kapoor","year":"2013","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2019.08.005_bib28","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00464-004-2287-z","article-title":"Multimodal therapy of anal cancer added by new endosonographic guided brachytherapy","volume":"20","author":"Doniec","year":"2006","journal-title":"Surg Endosc"},{"key":"10.1016\/j.brachy.2019.08.005_bib29","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1016\/S0167-8140(15)31158-0","article-title":"TRUS guided interstitial HDR Brachytherapy combined with RCT for treatment of anal cancer","volume":"111","author":"Niehoff","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2019.08.005_bib30","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0360-3016(00)01427-9","article-title":"Experience with split-course external beam irradiation \u00b1 chemotherapy and integrated Ir-192 high-dose-rate brachytherapy in the treatment of primary carcinomas of the anal canal","volume":"49","author":"Kapp","year":"2001","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.brachy.2019.08.005_bib31","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s13014-014-0240-4","article-title":"Interstitial high-dose rate brachytherapy as boost for anal canal cancer","volume":"9","author":"Falk","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.brachy.2019.08.005_bib32","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1200\/JCO.2011.35.4837","article-title":"Induction chemotherapy and dose Intensification of the radiation boost in locally advanced anal canal carcinoma: Final analysis of the randomized UNICANCER ACCORD 03 trial","volume":"30","author":"Peiffert","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2019.08.005_bib33","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.ijrobp.2010.02.055","article-title":"High dose split-course radiation therapy for anal cancer: Outcome analysis regarding the boost strategy (CORS-03study)","volume":"80","author":"Hannoun-Levi","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.08.005_bib34","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2478\/v10019-012-0022-2","article-title":"Long term outcome after combined modality treatment for anal cancer","volume":"46","author":"Oblak","year":"2012","journal-title":"Radiol Oncol"},{"key":"10.1016\/j.brachy.2019.08.005_bib35","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1016\/S0167-8140(15)32679-7","article-title":"Sphincter preservation in anal cancer: The EORTC PARADAC study","volume":"106","author":"Matzinger","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2019.08.005_bib36","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000071200","article-title":"Impact of overall treatment time on local control of anal cancer treated with radiochemotherapy","volume":"65","author":"Graf","year":"2003","journal-title":"Oncology"},{"key":"10.1016\/j.brachy.2019.08.005_bib37","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.radonc.2008.12.020","article-title":"Volumetric-modulated arc radiotherapy for carcinomas of the anal canal: A treatment planning comparison with fixed field IMRT","volume":"92","author":"Clivio","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2019.08.005_bib38","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1002\/cncr.31721","article-title":"Intensity-modulated radiotherapy improves survival and reduces treatment time in squamous cell carcinoma of the anus: A National Cancer Data Base study","volume":"124","author":"Elson","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.brachy.2019.08.005_bib39","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ijrobp.2005.02.030","article-title":"Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: Toxicity and clinical outcome","volume":"63","author":"Milano","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.08.005_bib40","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1200\/JCO.2007.12.0170","article-title":"Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: A multicenter experience","volume":"25","author":"Salama","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2019.08.005_bib41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijrobp.2012.09.023","article-title":"RTOG 0529: A phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal","volume":"86","author":"Kachnic","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.08.005_bib42","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.radonc.2017.11.018","article-title":"Phase I\u2013III development of the EORTC QLQ-ANL27, a health-related quality of life questionnaire for anal cancer","volume":"126","author":"Sodergren","year":"2018","journal-title":"Radiother Oncol"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472119304490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472119304490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:14:48Z","timestamp":1761531288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472119304490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1538472119304490"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2019.08.005","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-dose-rate vs. low-dose-rate interstitial brachytherapy boost for anal canal cancers","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2019.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}